Cargando…
Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease
Autor principal: | Jeong, Woo Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593318/ https://www.ncbi.nlm.nih.gov/pubmed/28874039 http://dx.doi.org/10.5009/gnl17333 |
Ejemplares similares
-
Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
por: Fujita, Nobuhiro, et al.
Publicado: (2016) -
Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?
por: Bhandari, Priyanka, et al.
Publicado: (2022) -
Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023) -
Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023) -
Nonalcoholic Fatty Liver Disease Progression in Rats is Accelerated by Splenic Regulation of Liver PTEN/AKT
por: Wang, Ziming, et al.
Publicado: (2015)